|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.115 USD | +1.14% |
|
+7.17% | -14.21% |
| 05-14 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
| Market Cap | 102M 89.88M 82.82M 77.53M 145M 9.69B 148M 994M 385M 4.76B 384M 376M 16.53B | P/E 2026 * |
1.28x | P/E 2027 * | 6.1x |
|---|---|---|---|---|---|
| Enterprise Value | 102M 89.88M 82.82M 77.53M 145M 9.69B 148M 994M 385M 4.76B 384M 376M 16.53B | EV / Sales 2026 * |
1.28x | EV / Sales 2027 * | 0.76x |
| Free-Float |
77.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fortress Biotech, Inc.
| 1 day | +1.14% | ||
| 1 week | +7.17% | ||
| Current month | +12.14% | ||
| 1 month | +16.73% | ||
| 3 months | +5.37% | ||
| 6 months | -12.78% | ||
| Current year | -14.21% |
| 1 week | 2.94 |  | 3.24 |
| 1 month | 2.53 | | 3.24 |
| Current year | 2.18 | | 4.53 |
| 1 year | 1.71 | | 4.53 |
| 3 years | 1.24 | | 10.35 |
| 5 years | 1.24 | | 57.15 |
| 10 years | 1.24 | | 91.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 20/12/2013 | |
Xiao Qin Lu
DFI | Director of Finance/CFO | 51 | 22/02/2012 |
David Jin
DFI | Director of Finance/CFO | 36 | 16/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jimmie Harvey
BRD | Director/Board Member | 74 | 01/12/2008 |
| Chairman | 71 | 20/12/2013 | |
J. Lobell
BRD | Director/Board Member | 63 | 01/06/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-01 | Free | Chief Financial Officer | 2,967 | 0.0096% | ||
| 03-18 | Free | Chief Executive Officer | 475,424 | 1.5318% | ||
| 03-18 | Free | Director | 475,424 | 1.5318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.14% | +7.17% | +83.63% | -63.80% | 102M | |
| +0.93% | +0.57% | +20.76% | -20.71% | 62.32B | |
| +1.66% | +0.68% | +53.10% | +200.79% | 53.94B | |
| -1.70% | +27.30% | +27.30% | +27.30% | 38.98B | |
| -0.74% | +6.17% | -53.36% | -60.27% | 37.89B | |
| +0.09% | +2.37% | +60.50% | -29.62% | 29.48B | |
| +4.31% | +11.57% | +140.79% | -47.84% | 23.55B | |
| +1.10% | +5.09% | +55.86% | +67.86% | 20.71B | |
| +1.53% | -1.16% | -1.54% | +143.24% | 16.71B | |
| +4.86% | +8.36% | +68.50% | +124.23% | 16.02B | |
| Average | +1.30% | +1.67% | +45.55% | +34.12% | 29.97B | |
| Weighted average by Cap. | +0.93% | +0.08% | +35.16% | +40.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.88M 70.17M 64.66M 60.53M 113M 7.57B 115M 776M 301M 3.71B 300M 293M 12.9B | 134M 118M 109M 102M 190M 12.71B 194M 1.3B 505M 6.24B 504M 493M 21.67B |
| Net income | 90.51M 79.51M 73.27M 68.59M 129M 8.57B 131M 880M 341M 4.21B 340M 332M 14.62B | 21.13M 18.56M 17.11M 16.01M 30M 2B 30.51M 205M 79.51M 982M 79.33M 77.62M 3.41B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/06/26 | $3.140 | +1.95% | 667,517 |
| 22/06/26 | $3.080 | +3.01% | 538,154 |
| 18/06/26 | $2.990 | -2.61% | 372,256 |
| 17/06/26 | $3.070 | +4.78% | 689,378 |
| 16/06/26 | $2.930 | +2.45% | 375,026 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBIO Stock
Select your edition
All financial news and data tailored to specific country editions
